Dynamic changes of protein corona compositions on the surface of zinc oxide nanoparticle in cell culture media

Abstract

The potential applications of nanomaterials used in nanomedicine as ingredients in drug delivery systems and in other products continue to expand. When nanomaterials are introduced into physiological environments and driven by energetics, they readily associate proteins forming a protein corona (PC) on their surface. This PC could result in an alteration of the nanomaterial’s surface characteristics, affecting their interaction with cells due to conformational changes in adsorbed protein molecules. However, our current understanding of nanobiological interactions is still very limited. Utilizing a liquid chromatography–mass spectroscopy/mass spectroscopy technology and a Cytoscape plugin (ClueGO) approach, we examined the composition of the PC for a set of zinc oxide nanoparticles (ZnONP) from cell culture media typically and further analyzed the biological interaction of identified proteins, respectively. In total, 36 and 33 common proteins were investigated as being bound to ZnONP at 5 min and 60 min, respectively. These proteins were further analyzed with ClueGO, a Cytoscape plugin, which provided gene ontology and the biological interaction processes of identified proteins. Proteins bound to the surface of nanoparticles that may modify the structure, therefore the function of the adsorbed protein could be consequently affect the complicated biological processes.

Graphical abstract

Keywords

ZnONPs / nanoparticles / protein corona / ClueGO

References

[1] Blunk T, Hochstrasser D F, Sanchez J C, Muller B W, Muller R H. Colloidal carriers for intravenous drug targeting: Plasma protein adsorption patterns on surface-modified latex particles evaluated by two-dimensional polyacrylamide gel electrophoresis. Electrophoresis, 1993, 14(12): 1382–1387

[2] Ehrenberg M S, Friedman A E, Finkelstein J N, Oberdorster G, McGrath J L. The influence of protein adsorption on nanoparticle association with cultured endothelial cells. Biomaterials, 2009, 30(4): 603–610

[3] Lundqvist M, Augustsson C, Lilja M, Lundkvist K, Dahlbäck B, Linse S, Cedervall T. The nanoparticle protein corona formed in human blood or human blood fractions. PLoS One, 2017, 12(4): e0175871

[4] Beduneau A, Ma Z, Grotepas C B, Kabanov A, Rabinow B E, Gong N, Mosley R L, Dou H, Boska M D, Gendelman H E. Facilitated monocyte-macrophage uptake and tissue distribution of superparmagnetic iron-oxide nanoparticles. PLoS One, 2009, 4(2): e4343

[5] Clift M J, Bhattacharjee S, Brown D M, Stone V. The effects of serum on the toxicity of manufactured nanoparticles. Toxicology Letters, 2010, 198(3): 358–365

[6] Khanna P, Ong C, Bay B H, Baeg G H. Nanotoxicity: An interplay of oxidative stress, inflammation and cell death. Nanomaterials (Basel, Switzerland), 2015, 5(3): 1163–1180

[7] Lartigue L, Wilhelm C, Servais J, Factor C, Dencausse A, Bacri J C, Luciani N, Gazeau F. Nanomagnetic sensing of blood plasma protein interactions with iron oxide nanoparticles: Impact on macrophage uptake. ACS Nano, 2012, 6(3): 2665–2678

[8] Lunov O, Syrovets T, Loos C, Beil J, Delacher M, Tron K, Nienhaus G U, Musyanovych A, Mailänder V, Landfester K, et al. Differential uptake of functionalized polystyrene nanoparticles by human macrophages and a monocytic cell line. ACS Nano, 2011, 5(3): 1657–1669

[9] Walkey C D, Olsen J B, Song F, Liu R, Liu R, Guo H, Olsen D W, Cohen Y, Emili A, Chan W C. Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles. ACS Nano, 2014, 8(3): 2439–2455

[10] Gu Z, Yang Z, Chong Y, Ge C, Weber J K, Bell D R, Zhou R. Surface curvature relation to protein adsorption for carbon-based nanomaterials. Scientific Reports, 2015, 5(1): 10886

[11] Marucco A, Gazzano E, Ghigo D, Enrico E, Fenoglio I. Fibrinogen enhances the inflammatory response of alveolar macrophages to TiO₂, SiO₂ and carbon nanomaterials. Nanotoxicology, 2016, 10(1): 1–9

[12] Ge C, Du J, Zhao L, Wang L, Liu Y, Li D, Yang Y, Zhou R, Zhao Y, Chai Z, Chen C. Binding of blood proteins to carbon nanotubes reduces cytotoxicity. Proceedings of the National Academy of Sciences of the United States of America, 2011, 108(41): 16968–16973

[13] Hajipour M J, Raheb J, Akhavan O, Arjmand S, Mashinchian O, Rahman M, Abdolahad M, Serpooshan V, Laurentj L, Mahmoudi M. Personalized disease-specific protein corona influences the therapeutic impact of graphene oxide. Nanoscale, 2015, 7(19): 8978–8994

[14] Salvati A, Pitek A S, Monopoli M P, Prapainop K, Bombelli F B, Hristov D R, Kelly P M, Åberg C, Mahon E, Dawson K A. Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. Nature Nanotechnology, 2013, 8(2): 137–143

[15] Deng Z J, Liang M, Monteiro M, Toth I, Minchin R F. Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation. Nature Nanotechnology, 2011, 6(1): 39–44

[16] Saikia J, Yazdimamaghani M, Hadipour M. S P, Ghandehari H. Differential protein adsorption and cellular uptake of silica nanoparticles based on size and porosity. ACS Applied Materials & Interfaces, 2016, 8(50): 34820–34832

[17] Anders C B, Eixenberger J E, Franco N A, Hermann R J, Rainey K D, Chess J J, Punnooseb A, Wingett D G. ZnO nanoparticle preparation route influences surface reactivity, dissolution and cytotoxicity. Environmental Science. Nano, 2018, 5(2): 572–588

[18] Rasmussen J W, Martinez E, Louka P, Denise G, Wingett D G. Zinc oxide nanoparticles for selective destruction of tumor cells and potential for drug delivery applications. Expert Opinion on Drug Delivery, 2010, 7(9): 1063–1077

[19] Scherzad A, Meyer T, Kleinsasser N, Hackenberg S. Molecular mechanisms of zinc oxide nanoparticle-induced genotoxicity short running title: Genotoxicity of ZnO NPs. Materials (Basel), 2017, 10(12): e1427

[20] Singh N, Manshian B, Jenkins G J, Griffiths S M, Williams P M, Maffeis T G, Wright C J, Doak S H. Nanogenotoxicology: The DNA damaging potential of engineered nanomaterials. Biomaterials, 2009, 30(23-24): 3891–3914

[21] Rajput V D, Minkina T M, Behal A, Sushkova S N, Mandzhieva S, Singh R, Gorovtsov A, Tsitsuashvili V S, Purvis W O, Ghazaryan K A, et al. Effects of zinc-oxide nanoparticles on soil, plants, animals and soil organisms: A review. Environmental Nanotechnology, Monitoring & Management, 2018, 9: 76–84

[22] Wahab R, Siddiqui M A, Saquib Q, Dwivedi S, Ahmad J, Musarrat J, Al-Khedhairy A A, Shin H S. ZnO nanoparticles induced oxidative stress and apoptosis in HepG2 and MCF-7 cancer cells and their antibacterial activity. Colloids and Surfaces. B, Biointerfaces, 2014, 117(1): 267–276

[23] Chevallet M, Gallet B, Fuchs A, Jouneau P H, Um K, Mintz E, Michaud-Soret I. Metal homeostasis disruption and mitochondrial dysfunction in hepatocytes exposed to sub-toxic doses of zinc oxide nanoparticles. Nanoscale, 2016, 8(43): 18495–18506

[24] Zhang W, Zhao Y, Li F, Li L, Feng Y, Min L, Ma D, Yu S, Liu J, Zhang H, et al. Zinc oxide nanoparticle caused plasma metabolomic perturbations correlate with hepatic steatosis. Frontiers in Pharmacology, 2018, 9: 57

[25] Leite-Silva V R, Liu D C, Sanchez W Y, Studier H, Mohammed Y H, Holmes A, Becker W, Grice J E, Benson H A, Roberts M S. Effect of flexing and massage on in vivo human skin penetration and toxicity of zinc oxide nanoparticles. Nanomedicine (London), 2016, 11(10): 1193–1205

[26] Sayes C M, Reed K L, Warheit D B. Assessing toxicity of fine and nanoparticles: Comparing in vitro measurements to in vivo pulmonary toxicity profiles. Toxicological Sciences: An Official Journal of the Society of Toxicology, 2007, 97(1): 163–180

[27] Xia T, Zhao Y, Sager T, George S, Pokhrel S, Li N, Schoenfeld D, Meng H, Lin S, Wang X, et al. Decreased dissolution of ZnO by iron doping yields nanoparticles with reduced toxicity in the rodent lung and zebrafish embryos. ACS Nano, 2011, 5(2): 1223–1235

[28] Warheit D B, Sayes C M, Reed K L. Nanoscale and fine zinc oxide particles: Can in vitro assays accurately forecast lung hazards following inhalation exposures? Environmental Science & Technology, 2009, 43(20): 7939–7945

[29] Giau V V, An S S. Emergence of exosomal miRNAs as a diagnostic biomarker for Alzheimer’s disease. Journal of the Neurological Sciences, 2016, 15(360): 141–152

[30] Mana M N, Fougères P A, Leung Y H, Liu F, Djurišić A B, Giesy J P, Leung K M Y. Physicochemical characteristics and toxicity of surface-modified zinc oxide nanoparticles to freshwater and marine microalgae. Scientific Reports, 2017, 7(1): 15909

[31] Milani S, Bombelli F B, Pitek A S, Dawson K A, Rädler J. Reversible versus irreversible binding of transferrin to polystyrene nanoparticles: Soft and hard corona. ACS Nano, 2012, 6(3): 2532–2541

[32] Pederzoli F, Tosi G, Vandelli M A, Belletti D, Forni F, Ruozi B. Protein corona and nanoparticles: How can we investigate on? Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology, 2017, 9(6): e1467

[33] Rao A, Long H, Harley-Trochimczyk A, Pham T, Zettl A, Carraro C, Maboudian R. In situ localized growth of ordered metal oxide hollow sphere array on microheater platform for sensitive, ultra-fast gas sensing. ACS Applied Materials & Interfaces, 2017, 9(3): 2634–2641

[34] Schöttler S, Landfester K, Mailänder V. Controlling the stealth effect of nanocarriers through understanding the protein corona. Angewandte Chemie International Edition in English, 2016, 55(31): 8806–8815

[35] Tenzer S, Docter D, Kuharev J, Musyanovych A, Fetz V, Hecht R, Schlenk F, Fischer D, Kiouptsi K, Reinhardt C, et al. Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. Nature Nanotechnology, 2013, 8(10): 772–781

[36] Saha K, Rahimi M, Yazdani M, Kim S T, Moyano D F, Hou S, Das R, Mout R, Rezaee F, Mahmoudi M, et al. Regulation of macrophage recognition through the interplay of nanoparticle surface functionality and protein corona. ACS Nano, 2016, 10(4): 4421–4430

[37] Shannahan J H, Brown J M, Chen R, Ke P C, Lai X, Mitra S, Witzmann F A. Comparison of nanotube-protein corona composition in cell culture media. Small, 2013, 9(12): 2171–2181

[38] Shannahan J H, Lai X, Ke P C, Podila R, Brown J M, Witzmann F A. Silver nanoparticle protein corona composition in cell culture media. PLoS One, 2013, 8(9): e74001

[39] Kim K M, Choi M H, Lee J K, Jeong J, Kim Y R, Kim M K, Paek S M, Oh J M. Physicochemical properties of surface charge-modified ZnO nanoparticles with different particle sizes. International Journal of Nanomedicine, 2014, 9(Suppl 2): 41–56

[40] Shim K H, Hulme J, Maeng E H, Kim M K. An S S A. Analysis of zinc oxide nanoparticles binding proteins in rat blood and brain homogenate. International Journal of Nanomedicine, 2014, 9(Suppl 2): 217–224

[41] Cedervall T, Lynch I, Foy M, Berggård T, Donnelly S C, Cagney G, Linse S, Dawson K A. Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. Angewandte Chemie International Edition in English, 2007, 46(30): 5754–5756

[42] Lara S, Alnasser F, Polo E, Garry D, Giudice M C L, Hristov D R, Rocks L, Salvati A, Yan Y, Dawso N K A. Identification of receptor binding to the biomolecular corona of nanoparticles. ACS Nano, 2017, 11(2): 1884–1893

[43] Kreuter J, Shamenkov D, Petrov V, Ramge P, Cychutek K, Koch-Brandt C, Alyautdin R. Apolipoprotein-mediated transport of nanoparticle-bond drugs across the blood-brain barrier. Journal of Drug Targeting, 2002, 10(4): 317–325

[44] Palchetti S, Colapicchioni V, Digiacomo L, Caracciolo G, Pozzi D, Capriotti A L, La Barbera G, Laganà A. The protein corona of circulating PEGylated liposomes. Biochimica et Biophysica Acta, 2016, 1858(2): 189–196

[45] Ritz S, Schöttler S, Kotman N, Baier G, Musyanovych A, Kuharev J, Landfester K, Schild H, Jahn O, Tenzer S, et al. Protein corona of nanoparticles: Distinct proteins regulate the cellular uptake. Biomacromolecules, 2015, 16(4): 1311–1321

[46] Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, Dawson K A. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proceedings of the National Academy of Sciences of the United States of America, 2008, 105(38): 14265–14270

[47] Townson J L, Lin Y S, Agola J O, Carnes E C, Leong H S, Lewis J D, Haynes C L, Brinker C J. Differing in vivo characteristics of size- and charge-matched mesoporous silica nanoparticles. Journal of the American Chemical Society, 2013, 135(43): 16030–16033

[48] Röcker C, Pötzl M, Zhang F, Parak W J, Nienhaus G U. A quantitative fluorescence study of protein monolayer formation on colloidal nanoparticles. Nature Nanotechnology, 2009, 4(9): 577–580

[49] Deng Z J, Mortimer G, Schiller T, Musumeci A, Martin D, Minchin R F. Differential plasma protein binding to metal oxide nanoparticles. Nanotechnology, 2009, 20(45): 455101

[50] Lesniak A, Campbell A, Monopoli M P, Lynch I, Salvati A, Dawson K A. Serum heat inactivation affects protein corona composition and nanoparticle uptake. Biomaterials, 2010, 31(36): 9511–5918

[51] Lesniak A, Fenaroli F, Monopoli M P, Åberg C, Dawson K A, Salvati A. Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells. ACS Nano, 2012, 6(7): 5845–5857

[52] Lesniak A, Salvati A, Santos-Martinez M J, Radomski M W, Dawson K A, Åberg C. Nanoparticle adhesion to the cell membrane and its effect on nanoparticle uptake efficiency. Journal of the American Chemical Society, 2013, 135(4): 1438–1444

[53] Murdock R C, Braydich-Stolle L, Schrand A M, Schlager J J, Hussain S M. Characterization of nanomaterial dispersion in solution prior to in vitro exposure using dynamic light scattering technique. Toxicological Sciences: An Official Journal of the Society of Toxicology, 2008, 101(2): 239–253

[54] Maiorano G, Sabella S, Sorce B, Brunetti V, Malvindi M A, Cingolani R, Pompa P P. Effects of cell culture media on the dynamic formation of protein-nanoparticle complexes and influence on the cellular response. ACS Nano, 2010, 4(12): 7481–7491

[55] Wang J, Jensen U B, Jensen G V, Shipovskov S, Balakrishnan V S, Otzen D, Pedersen J S, Besenbacher F, Sutherland D S. Soft interactions at nanoparticles alter protein function and conformation in a size dependent manner. Nano Letters, 2011, 11(11): 4985–4991

[56] Zhou Y, Fang X, Gong Y, Xiao A, Xie Y, Liu L, Cao Y. The interactions between ZnO nanoparticles (NPs) and α-linolenic acid (LNA) complexed to BSA did not influence the toxicity of ZnO NPs on HepG2 cells. Journal of the American Chemical Society, 2017, 135(4): 1438–1444

[57] Go M R, Yu J, Bae S H, Kim H J, Choi S J. Effects of interactions between ZnO nanoparticles and saccharides on biological responses. International Journal of Molecular Sciences, 2018, 19(2): 486

Acknowledgement

This research was supported by a National Research Foundation of Korea (NRF) awarded by the Korean government (NRF-2017R1A2B4012636).

RIGHTS & PERMISSIONS

2019 Higher Education Press and Springer-Verlag GmbH Germany, part of Springer Nature